spacer
spacer

PDBsum entry 1ef3

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Oxidoreductase PDB id
1ef3

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
315 a.a. *
Ligands
NAP ×2
FID ×2
Waters ×25
* Residue conservation analysis
PDB id:
1ef3
Name: Oxidoreductase
Title: Fidarestat bound to human aldose reductase
Structure: Aldose reductase. Chain: a, b. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Tissue: muscle. Expressed in: unidentified baculovirus. Expression_system_taxid: 10469
Resolution:
2.80Å     R-factor:   0.186     R-free:   0.278
Authors: M.Oka,Y.Matsumoto,S.Sugiyama,N.Tsuruta,M.Matsushima
Key ref: M.Oka et al. (2000). A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2', 5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide (Fidarestat): its absolute configuration and interactions with the aldose reductase by X-ray crystallography. J Med Chem, 43, 2479-2483. PubMed id: 10882376 DOI: 10.1021/jm990502r
Date:
06-Feb-00     Release date:   07-Feb-01    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P15121  (ALDR_HUMAN) -  Aldo-keto reductase family 1 member B1 from Homo sapiens
Seq:
Struc:
316 a.a.
315 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 1: E.C.1.1.1.21  - aldose reductase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. an alditol + NAD+ = an aldose + NADH + H+
2. an alditol + NADP+ = an aldose + NADPH + H+
alditol
+
NAD(+)
Bound ligand (Het Group name = NAP)
matches with 91.67% similarity
= aldose
+ NADH
+ H(+)
alditol
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= aldose
+ NADPH
+ H(+)
   Enzyme class 2: E.C.1.1.1.300  - NADP-retinol dehydrogenase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: all-trans-retinol + NADP+ = all-trans-retinal + NADPH + H+
all-trans-retinol
Bound ligand (Het Group name = FID)
matches with 41.38% similarity
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= all-trans-retinal
+ NADPH
+ H(+)
   Enzyme class 3: E.C.1.1.1.372  - D/L-glyceraldehyde reductase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. glycerol + NADP+ = L-glyceraldehyde + NADPH + H+
2. glycerol + NADP+ = D-glyceraldehyde + NADPH + H+
glycerol
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= L-glyceraldehyde
+ NADPH
+ H(+)
glycerol
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= D-glyceraldehyde
+ NADPH
+ H(+)
   Enzyme class 4: E.C.1.1.1.54  - allyl-alcohol dehydrogenase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: allyl alcohol + NADP+ = acrolein + NADPH + H+
allyl alcohol
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= acrolein
+ NADPH
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1021/jm990502r J Med Chem 43:2479-2483 (2000)
PubMed id: 10882376  
 
 
A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2', 5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide (Fidarestat): its absolute configuration and interactions with the aldose reductase by X-ray crystallography.
M.Oka, Y.Matsumoto, S.Sugiyama, N.Tsuruta, M.Matsushima.
 
  ABSTRACT  
 
The absolute configuration of the aldose reductase (AR) inhibitor, (+)-(2S,4S)-6-fluoro-2',5'-dioxospiro¿chroman-4, 4'-imidazolidine-2-carboxamide (fidarestat), was established indirectly by single-crystal X-ray analysis of (+)-(2S, 4S)-8-bromo-6-fluoro-2',5'-dioxospiro¿chroman-4, 4'-imidazolidine-2-carboxylic acid (1). The crystal structure of human AR complexed with fidarestat was determined, and the specific inhibition activity was discussed on the basis of the three-dimensional interactions between them. The structure clarified that fidarestat was located in the active site by hydrophilic and hydrophobic interactions and that the carbamoyl group of fidarestat was a very effective substituent for affinity to AR and for selectivity between AR and aldehyde reductase (AHR). Explanations for the differences between the observed activities of fidarestat and its stereoisomer 2 were suggested by computer modeling.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
21579711 P.Chen, S.Qian, Z.Q.Shi, and Y.Wu (2010).
6-Fluoro-4-oxochroman-2-carboxylic acid.
  Acta Crystallogr Sect E Struct Rep Online, 66, o274.  
19373836 J.C.Patra, and O.Singh (2009).
Artificial neural networks-based approach to design ARIs using QSAR for diabetes mellitus.
  J Comput Chem, 30, 2494-2508.  
19301313 M.Eisenmann, H.Steuber, M.Zentgraf, M.Altenkämper, R.Ortmann, J.Perruchon, G.Klebe, and M.Schlitzer (2009).
Structure-based optimization of aldose reductase inhibitors originating from virtual screening.
  ChemMedChem, 4, 809-819.
PDB code: 3dn5
16699182 D.E.Danley (2006).
Crystallization to obtain protein-ligand complexes for structure-aided drug design.
  Acta Crystallogr D Biol Crystallogr, 62, 569-575.  
15970585 E.K.Bomati, M.B.Austin, M.E.Bowman, R.A.Dixon, and J.P.Noel (2005).
Structural elucidation of chalcone reductase and implications for deoxychalcone biosynthesis.
  J Biol Chem, 280, 30496-30503.
PDB code: 1zgd
15272156 F.Ruiz, I.Hazemann, A.Mitschler, A.Joachimiak, T.Schneider, M.Karplus, and A.Podjarny (2004).
The crystallographic structure of the aldose reductase-IDD552 complex shows direct proton donation from tyrosine 48.
  Acta Crystallogr D Biol Crystallogr, 60, 1347-1354.
PDB codes: 1t40 1t41
15146479 O.El-Kabbani, C.Darmanin, T.R.Schneider, I.Hazemann, F.Ruiz, M.Oka, A.Joachimiak, C.Schulze-Briese, T.Tomizaki, A.Mitschler, and A.Podjarny (2004).
Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors.
  Proteins, 55, 805-813.
PDB codes: 1pwl 1pwm
15146480 O.Kraemer, I.Hazemann, A.D.Podjarny, and G.Klebe (2004).
Virtual screening for inhibitors of human aldose reductase.
  Proteins, 55, 814-823.  
12548088 M.Goto, Y.Yamauchi, E.Kurosaki, and H.Azuma (2003).
Possible involvement of facilitated polyol pathway in augmentation of intimal hyperplasia in rabbits with alloxan-induced hyperglycemia.
  J Cardiovasc Pharmacol, 41, 265-275.  
12486717 O.El-Kabbani, P.Ramsland, C.Darmanin, R.P.Chung, and A.Podjarny (2003).
Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme.
  Proteins, 50, 230-238.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer